42 results on '"Van Eijk, Ruben P.A."'
Search Results
2. The Effects of a Blended Care Intervention in Partners of Patients With Acquired Brain Injury – Results of the CARE4Carer Randomized Controlled Trial
3. Enhanced low-threshold motor unit capacity during endurance tasks in patients with spinal muscular atrophy using pyridostigmine
4. Continuous Theta-Burst Stimulation of the Contralesional Primary Motor Cortex for Promotion of Upper Limb Recovery After Stroke: A Randomized Controlled Trial
5. Joint modeling of endpoints can be used to answer various research questions in randomized clinical trials
6. Monitoring Nusinersen Treatment Effects in Children with Spinal Muscular Atrophy with Quantitative Muscle MRI
7. Motor unit reserve capacity in spinal muscular atrophy during fatiguing endurance performance
8. The ALSFRS-R Summit: a global call to action on the use of the ALSFRS-R in ALS clinical trials.
9. The Effects of a Blended Care Intervention in Partners of Patients With Acquired Brain Injury – Results of the CARE4Carer Randomized Controlled Trial
10. Incidence, Prevalence and Geographical Clustering of Motor Neuron Disease in the Netherlands
11. Assessment of risk of ALS conferred by the GGGGCC hexanucleotide repeat expansion in C9orf72 among first-degree relatives of patients with ALS carrying the repeat expansion.
12. Monitoring Nusinersen Treatment Effects in Children with Spinal Muscular Atrophy with Quantitative Muscle MRI.
13. Development of a Rasch-Built Amyotrophic Lateral Sclerosis Impairment Multidomain Scale to Measure Disease Progression in ALS
14. Increasing the efficiency of clinical trials in neurodegenerative disorders using group sequential trial designs
15. Development and Evaluation of a Simulation-Based Algorithm to Optimize the Planning of Interim Analyses for Clinical Trials in ALS
16. Association Between Serum Lipids and Survival in Patients With Amyotrophic Lateral Sclerosis
17. Muscle strength and motor function in adolescents and adults with spinal muscular atrophy
18. Current trends in the clinical trial landscape for amyotrophic lateral sclerosis
19. Nerve ultrasound for diagnosing chronic inflammatory neuropathy: A multicenter validation study
20. Portable fixed dynamometry enables home-based, reliable assessment of muscle strength in patients with amyotrophic lateral sclerosis: a pilot study.
21. Population-based analysis of survival in spinal muscular atrophy
22. Nerve ultrasound improves detection of treatment-responsive chronic inflammatory neuropathies
23. Statins do not increase risk of polyneuropathy: A case-control study and literature review
24. Natural course of scoliosis and lifetime risk of scoliosis surgery in spinal muscular atrophy
25. Refining eligibility criteria for amyotrophic lateral sclerosis clinical trials
26. Meta-analysis of pharmacogenetic interactions in amyotrophic lateral sclerosis clinical trials
27. Innovating Clinical Trials for Amyotrophic Lateral Sclerosis
28. Clinical relevance of testing for metabolic vitamin B12 deficiency in patients with polyneuropathy.
29. Functional Loss and Mortality in Randomized Clinical Trials for Amyotrophic Lateral Sclerosis: To Combine, or Not to Combine—That is the Estimand
30. Clinical trials in pediatric ALS: a TRICALS feasibility study
31. Advancing disease monitoring of amyotrophic lateral sclerosis with the compound muscle action potential scan
32. Clinical relevance of testing for metabolic vitamin B12 deficiency in patients with polyneuropathy
33. A roadmap for remote digital health technology for Motor Neuron Disease (Preprint)
34. An old friend who has overstayed their welcome: the ALSFRS-R total score as primary endpoint for ALS clinical trials
35. Correlates of Fatigability in Patients With Spinal Muscular Atrophy
36. TRICALS: creating a highway toward a cure
37. A placebo-controlled trial to investigate the safety and efficacy of Penicillin G/Hydrocortisone in patients with ALS (PHALS trial)
38. Relative hyperventilation in non-ventilated patients with spinal muscular atrophy
39. Implications of spirometric reference values for amyotrophic lateral sclerosis
40. Loss of appetite is associated with a loss of weight and fat mass in patients with amyotrophic lateral sclerosis
41. Comparing methods to combine functional loss and mortality in clinical trials for amyotrophic lateral sclerosis
42. Comment: Plateaus and reversals in ALS disease course or limitations of trial design?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.